1.jpg
2.jpg
3.jpg
4.jpg
6.jpg
     On Wednesday, May 11, The Hill convened a discussion on delivering innovative new treatments to rare disease patients. Topics of discussion included: public-private partnerships to develop treatments and bring them to market, the cutting-edge science and medicine driving rare disease advances, and the path to making care accessible to the patients who need it most.
1.jpg
2.jpg
3.jpg
4.jpg
6.jpg
     On Wednesday, May 11, The Hill convened a discussion on delivering innovative new treatments to rare disease patients. Topics of discussion included: public-private partnerships to develop treatments and bring them to market, the cutting-edge science and medicine driving rare disease advances, and the path to making care accessible to the patients who need it most.
 On Wednesday, May 11, The Hill convened a discussion on delivering innovative new treatments to rare disease patients. Topics of discussion included: public-private partnerships to develop treatments and bring them to market, the cutting-edge science and medicine driving rare disease advances, and the path to making care accessible to the patients who need it most.
info
prev / next